These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24887297)

  • 1. Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.
    Gruel N; Benhamo V; Bhalshankar J; Popova T; Fréneaux P; Arnould L; Mariani O; Stern MH; Raynal V; Sastre-Garau X; Rouzier R; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2014 May; 16(3):R46. PubMed ID: 24887297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
    Maguire SL; Peck B; Wai PT; Campbell J; Barker H; Gulati A; Daley F; Vyse S; Huang P; Lord CJ; Farnie G; Brennan K; Natrajan R
    J Pathol; 2016 Nov; 240(3):315-328. PubMed ID: 27512948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
    Pang JB; Savas P; Fellowes AP; Mir Arnau G; Kader T; Vedururu R; Hewitt C; Takano EA; Byrne DJ; Choong DY; Millar EK; Lee CS; O'Toole SA; Lakhani SR; Cummings MC; Mann GB; Campbell IG; Dobrovic A; Loi S; Gorringe KL; Fox SB
    Mod Pathol; 2017 Jul; 30(7):952-963. PubMed ID: 28338653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.
    Pareja F; Selenica P; Brown DN; Sebastiao APM; da Silva EM; Da Cruz Paula A; Del A; Fu L; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
    Histopathology; 2019 Jul; 75(1):139-145. PubMed ID: 30843622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significance.
    Kramer Z; Kenessey I; Gángó A; Lendvai G; Kulka J; Tőkés AM
    Sci Rep; 2021 Sep; 11(1):18484. PubMed ID: 34531452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIN7A is a major determinant of cell-polarity defects in breast carcinomas.
    Gruel N; Fuhrmann L; Lodillinsky C; Benhamo V; Mariani O; Cédenot A; Arnould L; Macgrogan G; Sastre-Garau X; Chavrier P; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2016 Feb; 18(1):23. PubMed ID: 26887652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study.
    Magnoni F; Bianchi B; Pagan E; Corso G; Sala I; Bagnardi V; Claudia S; Brancaccio R; Bottazzoli E; Boato A; Munzone E; Dellapasqua S; Fusco N; Viviana G; Veronesi P
    Breast Cancer Res Treat; 2024 Nov; 208(2):333-347. PubMed ID: 38963526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast.
    Li S; Yang C; Zhai L; Zhang W; Yu J; Gu F; Lang R; Fan Y; Gong M; Zhang X; Fu L
    Breast Cancer Res Treat; 2012 Nov; 136(1):77-87. PubMed ID: 22976804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
    Duprez R; Wilkerson PM; Lacroix-Triki M; Lambros MB; MacKay A; A'Hern R; Gauthier A; Pawar V; Colombo PE; Daley F; Natrajan R; Ward E; MacGrogan G; Arbion F; Michenet P; Weigelt B; Vincent-Salomon A; Reis-Filho JS
    J Pathol; 2012 Feb; 226(3):427-441. PubMed ID: 22025283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast.
    Meng F; Liu B; Xie G; Song Y; Zheng X; Qian X; Li S; Jia H; Zhang X; Zhang L; Yang YL; Fu L
    Breast Cancer Res Treat; 2017 Nov; 166(2):383-392. PubMed ID: 28755148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
    Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
    Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
    Sagnak Yilmaz Z; Sarioglu S
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China.
    Liu Y; Huang X; Bi R; Yang W; Shao Z
    PLoS One; 2014; 9(9):e106564. PubMed ID: 25188383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [PSCA expression in invasive micropapillary carcinoma of breast].
    Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropapillary breast carcinoma in comparison with invasive duct carcinoma. Does it have an aggressive clinical presentation and an unfavorable prognosis?
    Elzohery YHAM; Radwan AH; Gareer SWY; Mamdouh MM; Moaz I; Khalifa AM; Mohen OA; Elithy MFAA; Hassaan M
    BMC Cancer; 2024 Aug; 24(1):992. PubMed ID: 39129012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
    Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
    J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.